SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13 | -99.9% | 82 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | 0.0% | 82 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | 0.0% | 82 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | +30.0% | 82 | -54.9% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 182 | +6.4% | 0.00% | – |
| Q1 2021 | $12,000 | -25.0% | 171 | -2.8% | 0.00% | -100.0% |
| Q4 2020 | $16,000 | – | 176 | +5766.7% | 0.00% | – |
| Q3 2020 | $0 | – | 3 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -97.9% | 23 | -96.5% | 0.00% | -100.0% |
| Q4 2019 | $48,000 | -50.5% | 660 | -1.2% | 0.00% | -33.3% |
| Q3 2019 | $97,000 | +4750.0% | 668 | +5972.7% | 0.01% | – |
| Q1 2019 | $2,000 | -95.8% | 11 | -97.9% | 0.00% | -100.0% |
| Q4 2018 | $48,000 | -36.8% | 534 | -0.4% | 0.00% | 0.0% |
| Q3 2018 | $76,000 | -10.6% | 536 | -1.3% | 0.00% | -25.0% |
| Q2 2018 | $85,000 | +8400.0% | 543 | +10760.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 5 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 5 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 5 | -54.5% | 0.00% | – |
| Q1 2016 | $2,000 | +100.0% | 11 | -47.6% | 0.00% | – |
| Q4 2015 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |